| |
| Magyar Immunológiai Társaság |
|
| Cross-Border Healthcare in Europe: |
 Rendezvény kezdete: 2013.02.26. | Rendezvény vége: 2013.02.26. |
| Helyszín: Belgium, Brussels, The Silken Berlaymont Hotel |
| A rendezvény Web oldala: http://publicpolicyexchange.co.uk/events/DB26-PPE2.php |
Cross-Border Healthcare in Europe:
Removing the Barriers to Deliver Clarity and Quality
The EU Directive on Patients’ Rights in Cross-Border Healthcare seeks to eliminate obstacles hindering patients from receiving treatment in another Member State. Rules for receiving cross-border healthcare and reimbursement of these costs are not always clear and, as such, the Directive provides more transparency and also clarifies who is responsible for quality and safety of care in cross-border settings.
This timely international symposium will tackle challenges to the implementation of cross-border healthcare and its impact on patient safety and quality, health professionals’ mobility and European standards for healthcare services.
|
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| Cross-Border Healthcare in Europe: |
| Rendezvény kezdete: 2013.02.26. | Rendezvény vége: 2013.02.26. |
| Helyszín: Belgium, Brussels, The Silken Berlaymont Hotel |
| A rendezvény Web oldala: http://publicpolicyexchange.co.uk/events/DB26-PPE2.php |
Cross-Border Healthcare in Europe:
Removing the Barriers to Deliver Clarity and Quality
The EU Directive on Patients’ Rights in Cross-Border Healthcare seeks to eliminate obstacles hindering patients from receiving treatment in another Member State. Rules for receiving cross-border healthcare and reimbursement of these costs are not always clear and, as such, the Directive provides more transparency and also clarifies who is responsible for quality and safety of care in cross-border settings.
This timely international symposium will tackle challenges to the implementation of cross-border healthcare and its impact on patient safety and quality, health professionals’ mobility and European standards for healthcare services.
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| Cutaneous Lymphomas 2013 |
| Rendezvény kezdete: 2013.02.06. | Rendezvény vége: 2013.02.09. |
| Szervező: Annette Gleich |
| Munkahely neve: MCI Deutschland GmbH | MCI – Berlin Office |
| Címe: Markgrafenstrasse 56 | 10117 Berlin | Germany |
| Tel: +49 (0)30 20 45 90 |
| Fax: +49 (0)30 20 45 950 |
| E-mail: lymphomas2013@mci-group.com |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://www.cutaneouslymphomas2013.com/ |
2nd WCCL/6th ISBICL 2013
World Congress of Cutaneous Lymphomas (WCCL) and International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL)
Dear colleagues,
Following the immensely successful 1st World Congress of Cutaneous Lymphomas (WCCL) in Chicago with its clinical emphasis and the 5th International Symposium on the Biology and Immunology of Cutaneous Lymphoma (ISBICL) with its focus on basic and translational research, we are most delighted to invite you to join us at the 2nd WCCL/6th ISBICL 2013 in Berlin. This unique meeting will review both the latest research and development relating to cutaneous lymphomas and the clinical practice including new therapies and clinical trials. The congress is supported by the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium and the EORTC Cutaneous Lymphoma Task Force.
In addition to a rewarding congress program, the visit to Berlin will bring you right into touch with the profound political changes of recent years and into one of the most vibrant cultural centers of the world with numerous concerts, operas, theaters, cabarets, museums, exhibitions, fairs and off-stage events. All who have visited the city before will be amazed of the rapid developments and will find ever new paths to explore.
We look forward to welcoming you in Berlin for a certainly most exciting congress and a rich personal experience.
Yours cordially
The International Program Committee
The Local Organizing Committee
Abstract submission deadline extended until December 14, 2012
|
|
|
|
